September 15 (SeeNews) - A consortium of Britain's Frontier Pharma Limited and Russian LLC NPA Petrovax Pharm is the only bidder left in the race for a 25% state-owned stake in Serbia's drug maker Galenika, after the bids submitted by India's Cadila Pharmaceutical and Brazil's EMS SA were deemed invalid over procedural issues, Serbia said on Thursday.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
